COVID-19 & Cancer
We have collected trusted information about COVID-19 that is especially relevant to people with breast cancer. This page will be updated regularly during the pandemic.
Read More
FDA Approves MARGENZA™
On December 16, 2020, the FDA approved margetuximab-cmkb (MARGENZA™) in combination with chemotherapy, for treating metastatic HER2-positive breast cancer.
Treating Breast Cancer Brain Mets
Read further for an overview of current research and new therapies for breast cancer brain metastasis (BCBM).
What is a Washout Period?
Learn more about “washout periods” — what they are, why they are required, the ethical issues that exist, and the potential solutions being discussed.
What is Next-Generation Sequencing?
Next-generation sequencing (NGS) is when all of the genes in a tumor are tested for genomic mutations. Read the discussions about whether NGS improves survival and quality of life, and the ESMO recommendations regarding NSG for patients with metastatic cancers (including breast).
Lines of Therapy: New Drugs May Change MBC Treatment
Which therapy to use for the first, second or third line of treatment for metastatic breast cancer is now under rigorous research as more new therapies are available for treating MBC.
New To Clinical Trials?
The idea of finding and entering a clinical trial can seem daunting. Here’s a Clinical Trials Primer to get you started.
SEARCH OUR SITE
for past articles or specific information.